Final Program

336 WEDNESDAY • MAY 18
CLINICAL
YEAR IN REVIEW
CME Credits Available: 2.0
D1 CLINICAL YEAR IN REVIEW 4
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Gateway Ballroom 102-104 (South Building, Lower Level)
Target Audience
Providers including physicians, nurses, respiratory therapists, nurse practitioners,
physician assistants. Trainees including residents and fellows; clinical researchers.
Objectives
At the conclusion of this session, the participant will be able to:
• apply new clinical research knowledge to clinical practice;
• learn new findings about key conditions in pulmonary, critical care and sleep;
• have new strategies to manage the care of common conditions in pulmonary,
critical care, and sleep.
The annual Clinical Year in Review symposia topic reviews of the key clinical
research publications over the last year. Each speaker is asked to review the 5-7
most important and influential publications on their topic in the prior year.
Chairing: J.L. Taylor-Cousar, MD, Denver, CO
D.J. Lederer, MD, MS, New York, NY
D.W. Ford, MD, MSCR, Charleston, SC
9:00 Asthma
A. Sood, MD, MPH, Albuquerque, NM
9:30 Medical Education
J.W. McCallister, MD, Columbus, OH
10:00 Pulmonary Vascular Disease
H.J. Bogaard, MD, PhD, Amsterdam, Netherlands
10:30 ILD
D.J. Lederer, MD, MS, New York, NY
This session and the International Conference are supported by educational grants from
AstraZeneca LP, Boehringer Ingelheim Pharmaceuticals, Inc.
All CME sessions have been planned and implemented in accordance with the Essential
Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME)
and are free of the control of commercial interests.
D2
CLINICAL • TRANSLATIONAL
CLINICAL TOPICS IN PULMONARY MEDICINE
CME Credits Available: 2.0
WHAT, WHEN, WHERE: CLEARING THE AIR ON
STEM CELL THERAPIES IN PULMONARY
DISEASES
Assemblies on Clinical Problems; Respiratory Cell and Molecular
Biology
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Room 135 (North Building, Lower Level)
Target Audience
Providers of lung health; patients victimized by biotourism; researchers; clinicians.
Objectives
At the conclusion of this session, the participant will be able to:
• understand the terminology surrounding stem cell therapies;
• recognize the lack of efficacy data surrounding cell based therapies at this time;
• discuss future areas of investigation and application of cell based therapies in
lung disease.
This session will highlight seminal basic science information and recent advances in
the application of cell based therapeutics to the treatment of lung disease (IPF,
COPD, and ARDS). For patients and physicians who search for treatments for
incurable lung diseases, stem cell therapies have drawn increasing attention.
Unfortunately, patients become victims of biotourism. Several well designed and
completed phase 1 clinical trials have now been completed with mesenchymal stem
cells (MSCs) that demonstrate patient safety. The results of these trials will be
reviewed as they are paving the way for productive phase 2 and 3 studies and
ultimately new therapeutic modalities. Controversies and cautions will be addressed.
Chairing: M. Glassberg, MD, Miami, FL
V. Lama, MD, MS, Ann Arbor, MI
M. Rojas, MD, Pittsburgh, PA
9:00 Introduction and Overview
M. Glassberg, MD, Miami, FL
9:05 Vocabulary Check: Let’s All Talk the Same Language
V. Lama, MD, MS, Ann Arbor, MI
9:25 The Journey from Bench to Bedside: Deciphering How MSCs
Work
D.J. Weiss, MD, PhD, Burlington, VT
B. Thebaud, MD, PhD, Ottawa, Canada
9:45 Moving Stem Cell Therapies to Patients with IPF
M. Glassberg, MD, Miami, FL
10:05 The Stem Cells for ARDS Treatment Trial: What Lies Ahead
M.A. Matthay, MD, San Francisco, CA
10:25 A Note of Caution in Stem Cell Therapies: Separating the
Wheat from the Chaff
Speaker To Be Announced
10:45 Panel Discussion: Conclusions and Questions
V. Lama, MD, MS, Ann Arbor, MI
D3
BASIC • CLINICAL • TRANSLATIONAL
CLINICAL TOPICS IN PULMONARY MEDICINE
CME Credits Available: 2.0
TRANSLATIONAL ADVANCES IN PLEURAL
DISEASES: WHAT CLINICIANS NEED TO KNOW
Assembly on Clinical Problems
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Room 134 (North Building, Lower Level)
Target Audience
Clinicians and allied health professionals with clinical and research
responsibilities in respiratory diseases; especially chest physicians,
interventional pulmonologists, respiratory nurses, thoracic surgeons,
internists, general physicians and junior
ATS 2016 • San Francisco